000 | 01487nam a2200337 a 4500 | ||
---|---|---|---|
001 | 0000130415 | ||
005 | 20171002061022.0 | ||
006 | m u | ||
007 | cr cn||||||||| | ||
008 | 110215s2011 dcu sb 000 0 eng d | ||
020 | _z9780309163248 | ||
020 | _z0309163242 | ||
035 | _a(CaPaEBR)ebr10443278 | ||
035 | _a(OCoLC)707927323 | ||
040 |
_aCaPaEBR _cCaPaEBR |
||
050 | 1 | 4 |
_aR853.B54 _bM33 2011eb |
100 | 1 | _aMack, Alison. | |
245 | 1 | 0 |
_aPerspectives on biomarker and surrogate endpoint evaluation _h[electronic resource] : _bdiscussion forum summary / _cAlison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. |
260 |
_aWashington, D.C. : _bNational Academies Press, _c2011. |
||
300 | _ax, 129 p. | ||
504 | _aIncludes bibliographical references (p. 99-102). | ||
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2011. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 | _aBiochemical markers. | |
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 | _aBalogh, Erin. | |
700 | 1 | _aMicheel, Christine. | |
710 | 2 |
_aInstitute of Medicine (U.S.). _bCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. |
|
710 | 2 | _aebrary, Inc. | |
856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10443278 _zAn electronic book accessible through the World Wide Web; click to view |
908 | _a170314 | ||
942 | 0 | 0 | _cEB |
999 |
_c119564 _d119564 |